Cannabidiol

Cannabidiol

Best for

Reduce everyday pain intensity

Likely strong benefit · 45–600 mg/day for 1–9 weeks · 1 meta-analysis , n=378

12 papers · 11 claims · 47 outcomes scored · 7 positive

Outcomes

What cannabidiol actually does, by outcome

Each row is one outcome with effect size, evidence base, the dose that worked in trials, and time to first effect. Magnitude tiers come from native-unit MCID where available, Cohen's d otherwise.

Outcome Effect Evidence Dose Weeks Rank
Reduce everyday pain intensity Likely strong benefit
large
6 meta-analyses n=378 Meta-analyzed 45–600 mg 1–9 wk #6/55
Reduce seizure frequency in epilepsy Likely modest benefit
small
1 RCT n=149 50 mg/kg/day 16 wk
Lower day-to-day anxiety Not enough research
trivial
4 meta-analyses n=129 Meta-analyzed 50–600 mg 4 wk
Ease anxiety in older adults Not enough research
trivial
4 meta-analyses n=129 Meta-analyzed 50–600 mg 4 wk
Reduce pre-competition anxiety Not enough research
trivial
4 meta-analyses n=129 Meta-analyzed 50–600 mg 4 wk
Reduce daily stress Not enough research
trivial
2 RCTs n=48 50–600 mg 4 wk
Lift and steady your mood Not enough research
trivial
1 RCT n=48 600 mg #6/20
Improve overall sleep quality Not enough research
trivial
3 RCTs n=43 45–300 mg 8–9 wk
Ease depression symptoms Not enough research
trivial
2 RCTs n=43 45–600 mg 4–9 wk
Ease winter depression symptoms Not enough research
trivial
2 RCTs n=43 45–600 mg 4–9 wk
Ease depression tied to chronic pain Not enough research
trivial
2 RCTs n=43 45–600 mg 4–9 wk
Buy well

Recommended Cannabidiol products

Real products that dose Cannabidiol where the research does, in a clean formulation, from brands we've audited. We only list ones we'd stand behind.

Chosen for adequate Cannabidiol dosing vs. the studied range, a clean formulation (grade A–C), and independent brand-quality audits. Not sponsored.

Sources

  1. 1. Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD). (2019)
  2. 2. Acute effects of cannabinoids on symptoms of obsessive-compulsive disorder: A human laboratory study. (2020)
  3. 3. The acute effects of cannabidiol on emotional processing and anxiety: a neurocognitive imaging study. (2022)
  4. 4. Indications of Cannabinoids for the Palliation of Cancer-Associated Symptoms: A Systematic Review and Meta-Analysis. (2025)
  5. 5. Efficacy and safety of topical 0.1% cannabidiol for managing recurrent aphthous ulcers: a randomized controlled trial. (2023)
  6. 6. The Acute Effects of Cannabidiol on Physiological and Subjective Responses to Endurance Exercise: A Dose-Ranging Randomised Controlled Crossover Trial. (2025)
  7. 7. Effects and safety of a CBD-rich Cannabis sativa oil in knee osteoarthritis: a double-blind, randomized, placebo-controlled trial - CANOA - cannabis for osteoarthritis. (2025)
  8. 8. A preliminary randomized trial of the safety, tolerability, and clinical effects of hemp-derived cannabidiol in alcohol use disorder. (2025)
  9. 9. Vaporized cannabis versus placebo for acute migraine: A randomized, double-blind, placebo-controlled crossover trial. (2026)
  10. 10. Effects of Oral Cannabidiol on Health and Fitness in Healthy Adults: An 8-Week Randomized Trial. (2023)

Generated August 14, 2026

Want personalized recommendations?

Show me what works for me